Shareholders Approve Massive Dilution, Reverse Stock Split, and Equity Plan Repricing

summarizeSummary

Synergy CHC Corp. shareholders approved a highly dilutive equity incentive plan, the issuance of shares for a lender warrant, and a reverse stock split, confirming significant dilution and a move to address Nasdaq delisting.

check_boxKey Events · Financing and Capital Events · SNYR

• Massive Equity Plan Expansion Approved

  Shareholders approved an amendment to the 2024 Equity Incentive Plan, increasing the shares available for issuance to 150,000,000. This represents over 1,000% potential dilution based on current outstanding shares.

• Lender Warrant Share Issuance Approved

  Stockholders approved the full issuance of shares upon exercise of a Lender Warrant, which was previously tied to a $36 million equity line of credit and involved the registration of 101.7 million shares for resale. This adds substantial potential dilution.

• Award Repricing Permitted

  The approved amendment to the 2024 Equity Incentive Plan also permits the repricing of outstanding awards, which can further dilute existing shareholders by making options/warrants more likely to be exercised.

• Reverse Stock Split Authorized

  Shareholders approved a reverse stock split at a ratio of up to 1-for-200, a measure often used by companies to regain compliance with exchange minimum bid price requirements, following a recent Nasdaq delisting notice.

auto_awesomeAnalysis · SNYR · Life Sciences

Shareholders have approved several critical proposals, including a significant increase in the equity incentive plan to 150 million shares and the full issuance of shares tied to a lender warrant, which together represent potential dilution of over 1,600% compared to current outstanding shares. The approval also allows for repricing of outstanding awards, further disadvantaging existing shareholders. Additionally, a reverse stock split of up to 1-for-200 was approved, a defensive measure following a recent Nasdaq delisting notice for failing to meet the minimum bid price. These actions confirm a highly dilutive strategy to raise capital and maintain listing compliance amidst ongoing financial distress, as evidenced by prior reports of substantial net losses and increased cash burn.